In follow-up to the Forum on Neuroscience and Nervous System Disorders' March 2023 workshop on Multimodal Biomarker for Central Nervous System Disorders: Development, Integration and Clinical Utility, ...

The central nervous system (CNS) critically depends on the integrity of oligodendrocytes, specialised glial cells responsible for the formation and maintenance of myelin sheaths. Myelin not only ...

Racism, discrimination, and social determinants of health have contributed to clear disparities in health and health outcomes, particularly in central nervous system (CNS) disorders. Recognizing the ...

A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development.

BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) ...